Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry Task Force, FDA Set Timeline For Jumpstarting Third-Party Program

This article was originally published in The Gray Sheet

Executive Summary

A pan-industry/FDA task force will convene in the third week of April to discuss possible improvements to the agency's third party review program.

You may also be interested in...



FDA Enlists CEO Support To Invigorate Slumping Abbreviated 510(k) Program

CEO endorsement is essential to stimulate growth of FDA's abbreviated 510(k) program, staffers and industry representatives maintained at an AdvaMed standards conference in Rockville, Maryland Jan. 9-10.

FDA Enlists CEO Support To Invigorate Slumping Abbreviated 510(k) Program

CEO endorsement is essential to stimulate growth of FDA's abbreviated 510(k) program, staffers and industry representatives maintained at an AdvaMed standards conference in Rockville, Maryland Jan. 9-10.

FDA Pilots Expansion Of Third-Party Review To Devices Without Guidance

Only six of the twelve "accredited persons" have reviewed three or more 510(k) applications under the current third-party program, a requirement for participation in FDA's expanded third-party pilot.

Related Content

UsernamePublicRestriction

Register

MT013189

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel